Imperial Brands PLC (IMB.L)
Bristol, BSL, GB
Imperial Brands PLC, together with its subsidiaries, manufactures, imports, markets, and sells tobacco and tobacco-related products in Europe, the Americas, Africa, the Asia, Australasia, and internationally. It offers a range of cigarettes, tobacco accessories, vapour, heated tobacco, and oral nicotine. The company sells its products under various brands, including JPS, Davidoff, Gauloises, West, Winston, Kool, Lambert & Butler, P&S, Fortuna, Nobel, News, Backwoods, Champion, Golden Virginia, FINE, Rizla, Blu, Pulze, Skruf, and Zone. In addition, it engages in the distribution of tobacco and NGP products for tobacco and NGP product manufacturers; and various non-tobacco and NGP products and services. Further, the company is involved in the management of a golf course; distribution of pharmaceuticals, POS software, and published materials and other products; printing and publishing activities; and provision of long haul transportation, industrial parcel and express delivery, pharmaceutical products logistics, advertising, payment, freight forwarding, and support management services, as well as owns the trademarks; and retails its products. Additionally, it engages in edition and distribution of books and non-periodical publication. Furthermore, the company is involved in research and development of e-vapour products. The company was formerly known as Imperial Tobacco Group PLC and changed its name to Imperial Brands PLC in February 2016. Imperial Brands PLC was founded in 1636 and is based in Bristol, the United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.68% | +0.09% | -10.58% | -16.18% | -13.88% | -11.64% | -4.64% | +47.14% | +74.43% | -27.00% | +843.45% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | -1 |
| Buy | 6 | -1 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Tobacco: +5.3%-0.7% Q1'26: +5.4% (vs Q1'24)
-
EPS growth Tobacco: +18.8%-16.7% Q1'26: -69.3% (vs Q1'24)
-
FCF margin FCF growth · Tobacco: +9.5%+7.9% Q1'26: -5.3% (vs Q1'24)
-
EBIT margin Tobacco: +20.5%+11.1% Q1'26: +15.9% (vs Q1'24)
-
ROIC Tobacco: +16.0%+18.2% ★ Q1'26: +26.2% (vs Q1'24)
-
Share dilution Tobacco: +0.0%-5.0% ★ Q1'26: -9.7% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×2.29× Q1'26: 1.58× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2010 actual |
Sep 2011 actual |
Sep 2012 actual |
Sep 2013 actual |
Sep 2014 actual |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 8 Rev. Ana. 7 EPS Ana. |
Sep 2027 8 Rev. Ana. 7 EPS Ana. |
Sep 2028 1 Rev. Ana. 2 EPS Ana. |
Sep 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
28.17B
est: 8.05B (+249.8%)
|
29.22B
est: 8.01B (+264.9%)
|
28.57B
est: 8.06B (+254.7%)
|
28.27B
est: 7.95B (+255.7%)
|
26.46B
est: 7.51B (+252.5%)
|
25.29B
est: 7.22B (+250.1%)
|
27.63B
est: 7.94B (+247.8%)
|
30.25B
est: 8.60B (+251.7%)
|
30.07B
est: 8.57B (+251.0%)
|
31.59B
est: 8.99B (+251.5%)
|
32.56B
est: 8.90B (+266.0%)
|
32.79B
est: 8.67B (+278.2%)
|
32.55B
est: 8.82B (+268.9%)
|
32.48B
est: 18.18B (+78.6%)
|
32.41B
est: 9.31B (+248.1%)
|
32.17B
est: 9.75B (+229.9%)
|
9.92B
9.80B – 10.07B
+1.7% YoY
|
10.12B
9.93B – 10.29B
+2.1% YoY
|
10.33B
10.29B – 10.37B
+2.0% YoY
|
10.84B
10.67B – 11.01B
+4.9% YoY
|
| EBITDA |
3.36B
est: 213.06M (+1,478.4%)
|
3.52B
est: 2.36B (+48.9%)
|
3.59B
est: 2.27B (+58.2%)
|
3.14B
est: 2.38B (+32.1%)
|
3.14B
est: 1.63B (+93.1%)
|
3.33B
est: 1.92B (+72.9%)
|
2.84B
est: 2.70B (+5.3%)
|
3.91B
est: 872.79M (+347.5%)
|
3.73B
est: 2.79B (+33.8%)
|
3.62B
est: 2.58B (+40.4%)
|
3.62B
est: 2.38B (+52.0%)
|
4.58B
est: 2.39B (+91.0%)
|
4.93B
est: 2.48B (+98.3%)
|
4.25B
est: 2.49B (+70.4%)
|
4.14B
est: 2.52B (+64.0%)
|
4.37B
est: 1.34B (+226.8%)
|
1.36B
1.34B – 1.38B
+1.7% YoY
|
1.39B
1.36B – 1.41B
+2.1% YoY
|
1.42B
1.41B – 1.42B
+2.0% YoY
|
1.48B
1.46B – 1.51B
+4.9% YoY
|
| EBIT |
2.74B
est: 2.42B (+13.4%)
|
2.92B
est: 2.51B (+16.2%)
|
1.83B
est: 2.66B (-31.2%)
|
1.93B
est: 1.50B (+28.7%)
|
2.22B
est: 1.85B (+20.2%)
|
2.39B
est: 1.97B (+20.9%)
|
1.60B
est: 2.19B (-26.9%)
|
2.54B
est: 2.40B (+5.8%)
|
2.46B
est: 2.27B (+8.4%)
|
2.30B
est: 2.52B (-8.7%)
|
2.71B
est: 2.15B (+26.0%)
|
3.76B
est: 2.16B (+73.9%)
|
4.27B
est: 2.24B (+90.2%)
|
3.61B
est: 2.10B (+72.5%)
|
3.49B
est: 1.01B (+246.2%)
|
3.58B
est: 1.12B (+219.0%)
|
1.14B
1.13B – 1.16B
+1.7% YoY
|
1.17B
1.14B – 1.19B
+2.1% YoY
|
1.19B
1.19B – 1.19B
+2.0% YoY
|
1.25B
1.23B – 1.27B
+4.9% YoY
|
| Net Income |
1.51B
est: 685.73M (+119.5%)
|
1.80B
est: 1.50B (+20.0%)
|
678.00M
est: 1.81B (-62.5%)
|
905.00M
est: 668.77M (+35.3%)
|
1.42B
est: 854.94M (+66.3%)
|
1.69B
est: 1.39B (+21.6%)
|
631.00M
est: 1.86B (-66.1%)
|
1.41B
est: 679.92M (+107.2%)
|
1.37B
est: 1.40B (-2.6%)
|
1.01B
est: 1.43B (-29.6%)
|
1.50B
est: 988.33M (+51.3%)
|
2.83B
est: 994.16M (+185.1%)
|
1.57B
est: 1.67B (-5.9%)
|
2.33B
est: 1.93B (+20.8%)
|
2.61B
est: 2.44B (+7.0%)
|
2.07B
est: 2.60B (-20.3%)
|
2.81B
2.76B – 2.86B
+8.1% YoY
|
3.04B
2.95B – 3.13B
+8.1% YoY
|
3.35B
3.16B – 3.55B
+10.3% YoY
|
3.85B
3.78B – 3.93B
+14.9% YoY
|
| SGA |
2.00B
est: 2.05B (-2.2%)
|
2.81B
est: 1.99B (+41.2%)
|
2.79B
est: 2.02B (+38.2%)
|
2.35B
est: 1.98B (+18.8%)
|
2.20B
est: 1.94B (+13.4%)
|
2.12B
est: 1.89B (+12.3%)
|
2.42B
est: 2.05B (+18.1%)
|
2.67B
est: 2.23B (+19.5%)
|
2.35B
est: 2.43B (-3.0%)
|
2.49B
est: 2.21B (+12.7%)
|
2.65B
est: 2.25B (+18.1%)
|
2.45B
est: 2.26B (+8.6%)
|
2.34B
est: 2.34B (+0.0%)
|
3.28B
est: 1.66B (+97.5%)
|
3.23B
est: 2.38B (+35.5%)
|
3.51B
est: 890.16M (+294.5%)
|
905.61M
895.11M – 919.52M
+1.7% YoY
|
924.30M
906.89M – 939.22M
+2.1% YoY
|
943.19M
939.69M – 946.70M
+2.0% YoY
|
989.51M
974.41M – 1.01B
+4.9% YoY
|
| EPS |
1.49
est: 1.84 (-19.1%)
|
1.77
est: 1.94 (-8.6%)
|
0.68
est: 2.06 (-66.9%)
|
0.96
est: 2.15 (-55.4%)
|
1.49
est: 2.11 (-29.3%)
|
1.77
est: 2.08 (-14.7%)
|
0.66
est: 2.45 (-73.1%)
|
1.48
est: 2.72 (-45.6%)
|
1.44
est: 2.68 (-46.2%)
|
1.06
est: 2.76 (-61.6%)
|
1.58
est: 2.55 (-38.1%)
|
3.00
est: 2.44 (+22.9%)
|
1.66
est: 2.61 (-36.5%)
|
2.52
est: 2.32 (+8.5%)
|
3.01
est: 2.94 (+2.4%)
|
2.51
est: 3.12 (-19.5%)
|
3.36
3.32 – 3.44
+7.9% YoY
|
3.67
3.55 – 3.77
+9.1% YoY
|
4.04
3.80 – 4.27
+10.0% YoY
|
4.64
4.55 – 4.73
+14.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Murray McGowan | Chief Financial Officer & Director | 2M | male |
| Lukas Jean-Baptiste Paravicini | Chief Executive Officer & Director | 2M | male |
| Alison Clarke | Chief People & Culture Officer | — | female |
| Kevin Michael Massie | General Counsel | — | male |
| Kim Reed | President & CEO of Americas Region | — | female |
| Martin Goodall | Head of Sales | — | — |
| Peter Durman | Investor Relations Director | — | male |
| Ales Struminsky | President of Europe Region | — | male |
| Surinder Sond | Group Head of Sustainability | — | — |
| Alex Parsons | Director of Corporate Communications | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMB.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
